Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Pipeline Analysis

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1780872

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1780872

Glucagon

PUBLISHED:
PAGES: 368 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Glucagon Market to Reach US$547.2 Million by 2030

The global market for Glucagon estimated at US$434.2 Million in the year 2024, is expected to reach US$547.2 Million by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Injectable Glucagon, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$353.9 Million by the end of the analysis period. Growth in the Inhalation Glucagon segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$118.3 Million While China is Forecast to Grow at 7.1% CAGR

The Glucagon market in the U.S. is estimated at US$118.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$110.2 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Glucagon Market - Key Trends & Drivers Summarized

Why Is Glucagon a Critical Hormone in Metabolic and Emergency Medicine?

Glucagon, a peptide hormone produced by the pancreas, plays a vital role in glucose metabolism by stimulating the liver to release stored glucose, thereby increasing blood sugar levels. Traditionally known for its role in managing severe hypoglycemia in diabetic patients, glucagon has expanded its clinical applications beyond diabetes treatment. It is now being used in diagnostic imaging, gastrointestinal procedures, and even as a potential therapy for obesity and metabolic disorders. The growing prevalence of diabetes and the need for fast-acting, reliable treatments for hypoglycemic episodes have significantly boosted demand for glucagon-based therapies.

Recent advancements in glucagon formulations, including auto-injectors, nasal sprays, and long-acting analogs, have improved patient accessibility and ease of administration. These innovations have enhanced emergency hypoglycemia management, particularly for individuals who struggle with injectable treatments. Additionally, pharmaceutical companies are exploring novel applications for glucagon in metabolic disease modulation, including appetite regulation and energy balance, further expanding its therapeutic potential. As research continues to uncover new uses for glucagon, its role in modern medicine is becoming increasingly indispensable.

Which Medical Applications Are Driving Demand for Glucagon?

The primary use of glucagon remains in emergency medicine for the treatment of severe hypoglycemia in patients with type 1 and type 2 diabetes. Traditional glucagon injections and newer intranasal formulations are widely used by caregivers and healthcare providers to rapidly restore blood glucose levels in unconscious or severely hypoglycemic patients. However, recent advancements have expanded glucagon’s use into new therapeutic areas, including diagnostic imaging and gastrointestinal (GI) procedures.

In diagnostic imaging, glucagon is used as a smooth muscle relaxant to improve the visualization of the gastrointestinal tract during radiological procedures such as MRI and CT scans. Its ability to temporarily reduce peristalsis makes it valuable for obtaining high-quality images of the stomach and intestines. Additionally, ongoing research is investigating glucagon’s potential in obesity management, as it has been shown to suppress appetite and increase energy expenditure. With expanding applications in metabolic disease treatment and medical imaging, the demand for glucagon continues to rise across multiple healthcare sectors.

What Are the Latest Technological Innovations in Glucagon Drug Development?

Recent innovations in glucagon drug development have focused on improving formulation stability, ease of administration, and therapeutic efficacy. One of the most significant advancements is the introduction of ready-to-use auto-injectors and nasal spray formulations, which eliminate the need for reconstitution and improve emergency response times. These user-friendly delivery systems have increased glucagon adoption, particularly in home settings where rapid intervention is necessary.

Additionally, pharmaceutical companies are developing long-acting glucagon analogs designed for continuous glucose modulation in metabolic disorders. AI-driven drug discovery and peptide engineering techniques have enabled the optimization of glucagon analogs with improved pharmacokinetics, making them more suitable for long-term treatment applications. Furthermore, research into dual and triple hormone therapies combining glucagon with GLP-1 receptor agonists is gaining traction for treating obesity and type 2 diabetes. These advancements are positioning glucagon as a multi-functional hormone with significant therapeutic potential beyond emergency hypoglycemia management.

What Factors Are Fueling the Growth of the Glucagon Market?

The growth in the glucagon market is driven by several factors, including the rising incidence of diabetes, increasing awareness of hypoglycemia management, and expanding therapeutic applications. The growing diabetic population worldwide has heightened the demand for emergency glucagon treatments, particularly in home-use settings where caregivers require user-friendly solutions. The introduction of nasal and auto-injector formulations has further boosted adoption rates by improving ease of use.

Additionally, the expansion of glucagon’s role in diagnostic imaging and metabolic disease treatment has created new market opportunities. Regulatory approvals for novel formulations and combination therapies are further accelerating industry growth. Pharmaceutical companies investing in peptide engineering and next-generation glucagon analogs are driving innovation, positioning glucagon as a key player in future metabolic therapies. As demand for effective, versatile hormone-based treatments continues to rise, the glucagon market is expected to experience strong and sustained growth.

SCOPE OF STUDY:

The report analyzes the Glucagon market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Injectable Glucagon, Inhalation Glucagon); Application (Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application, Other Applications); Distribution Channel (Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Amphastar Pharmaceuticals, Inc.
  • Arecor Therapeutics plc
  • Aurobindo Pharma Limited
  • Avalon Pharma Private Limited
  • Bachem AG
  • Bachem Holding AG
  • Eli Lilly and Company
  • Fresenius SE & Co. KGaA
  • Fujifilm Holdings Corporation
  • Hybio Pharmaceutical
  • ILS Inc.
  • Jin Dun Medical
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Piramal Pharma Solutions
  • Svar Life Science
  • Taj Pharmaceuticals Limited
  • United Biotech (P) Limited
  • Xeris Biopharma Holdings, Inc.
  • Zealand Pharma A/S

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP31192

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Glucagon - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Hypoglycemia Among Diabetic Patients Drives Demand for Emergency Glucagon Products
    • Advancements in Ready-to-Use Auto-Injector and Nasal Spray Formats Enhance Patient Convenience
    • FDA and EMA Approvals of Non-Invasive Delivery Systems Accelerate Adoption in Pediatric and Elderly Populations
    • Rising Use of Glucagon in Off-Label and Diagnostic Applications Expands Market Scope
    • Integration into Emergency Kits and First Responder Protocols Supports Institutional Demand
    • Innovation in Synthetic and Recombinant Glucagon Reduces Dependence on Animal-Derived Sources
    • Growth in Diabetes Education and Awareness Campaigns Promotes Glucagon Access and Use Readiness
    • Strategic Partnerships Between Pharma and Medical Device Companies Drive Product Innovation
    • Expansion of Home Use and OTC-Approved Products Enhances Consumer Confidence and Accessibility
    • Emerging Use of Dual Hormone Artificial Pancreas Systems Integrates Glucagon for Better Glycemic Control
    • Increased Focus on Rare Endocrine Disorders and Post-Bariatric Applications Opens Specialized Use Cases
    • Growth in Digital Health and Connected Devices Enables Real-Time Glucagon Usage Monitoring
    • Competitive Differentiation Through Shelf-Stable and Heat-Resistant Formulations Gains Market Traction
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Glucagon Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Glucagon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Glucagon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Glucagon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Injectable Glucagon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Injectable Glucagon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Injectable Glucagon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Inhalation Glucagon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Inhalation Glucagon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Inhalation Glucagon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Online Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospital Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Retail Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hypoglycemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hypoglycemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hypoglycemia Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Aid Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostic Aid Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Diagnostic Aid Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Gastrointestinal Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Gastrointestinal Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Gastrointestinal Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Cardiogenic Shock Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Cardiogenic Shock Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Cardiogenic Shock Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Glucagon Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Glucagon Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Glucagon Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Glucagon Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Glucagon by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Glucagon by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Glucagon by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Glucagon Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Glucagon Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Glucagon Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Glucagon Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Glucagon by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Glucagon by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Glucagon by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Glucagon Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Glucagon Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Glucagon Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Glucagon by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Glucagon by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Glucagon by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Glucagon Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Glucagon by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Glucagon by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Glucagon by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Glucagon Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Glucagon by Product - Injectable Glucagon and Inhalation Glucagon Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Glucagon by Product - Percentage Breakdown of Value Sales for Injectable Glucagon and Inhalation Glucagon for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Glucagon by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Glucagon by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Glucagon by Application - Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Glucagon by Application - Percentage Breakdown of Value Sales for Hypoglycemia Application, Diagnostic Aid Application, Gastrointestinal Disorders Application, Cardiogenic Shock Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!